Pew Offers Comments on Increasing Price Transparency for Prescription Drugs in Oregon

Approach could lower drug costs for the state

Pew Offers Comments on Increasing Price Transparency for Prescription Drugs in Oregon

On Sept. 25, The Pew Charitable Trusts’ drug spending research initiative submitted comments to Oregon’s Joint Task Interim Force on Fair Pricing of Prescription Drugs on how increasing the transparency of drug prices could help lower costs to the state.

Pew’s comments summarize a policy option that could help Oregon’s Medicaid program secure larger drug rebates and avoid overpaying for medications by requiring drug manufacturers to confidentially report discounts provided to pharmacy benefit managers and other negotiating entities.  

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?